We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-0.01%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$35.6B
AUM Growth
+$1.38B
(+4%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
5.13%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
2,407
New
40
Increased
606
Reduced
1,352
Closed
406
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$172M |
| 2 |
Honeywell
HON
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$159M |
| 4 |
Amazon
AMZN
|
+$91M |
| 5 |
Tesla
TSLA
|
+$89.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.3M |
| 2 |
STMP
Stamps.com, Inc.
STMP
|
+$42.3M |
| 3 |
Magnite
MGNI
|
+$36.1M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$34.8M |
| 5 |
Etsy
ETSY
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Consumer Discretionary | 14.43% |
| 3 | Communication Services | 10.72% |
| 4 | Healthcare | 9.96% |
| 5 | Financials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Uranium Energy
UEC
$4.71B
| $90K | ﹤0.01% |
29,626
-25,438
| -46% | -$63.7K |
|
1927
Curis
CRIS
$9.53M
| $87K | ﹤0.01% |
28
-28
| -50% | -$87.4K |
|
1928
MiMedx Group
MDXG
$626M
| $86K | ﹤0.01% |
14,234
-14,586
| -51% | -$164K |
|
|
CBAY
1929
DELISTED
Cymabay Therapeutics
CBAY
| $86K | ﹤0.01% |
23,622
-6,756
| -22% | -$26.6K |
|
|
MCF
1930
DELISTED
Contango Oil & Gas Co.
MCF
| $86K | ﹤0.01% |
18,823
-19,286
| -51% | -$73.4K |
|
1931
Helix Energy Solutions
HLX
$1.46B
| $85K | ﹤0.01% |
22,000
-18,986
| -46% | -$78.2K |
|
|
CHS
1932
DELISTED
Chicos FAS, Inc.
CHS
| $83K | ﹤0.01% |
18,581
-15,963
| -46% | -$91.1K |
|
1933
Arlo Technologies
ARLO
$1.4B
| $82K | ﹤0.01% |
12,790
-10,542
| -45% | -$65.5K |
|
1934
Korro Bio
KRRO
$153M
| $81K | ﹤0.01% |
229
-60
| -21% | -$23.6K |
|
|
AUTL
1935
Autolus Therapeutics
AUTL
$386M
| $80K | ﹤0.01% |
+12,192
| New | +$77K |
|
1936
SunCoke Energy
SXC
$757M
| $80K | ﹤0.01% |
12,799
-11,028
| -46% | -$75.8K |
|
|
PRTK
1937
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $80K | ﹤0.01% |
16,524
-3,784
| -19% | -$20.9K |
|
|
RMO
1938
DELISTED
Romeo Power, Inc.
RMO
| $80K | ﹤0.01% |
16,142
+5,295
| +49% | +$31.7K |
|
|
TECX
1939
Tectonic Therapeutic
TECX
$573M
| $79K | ﹤0.01% |
1,181
-229
| -16% | -$18.8K |
|
|
ATRS
1940
DELISTED
Antares Pharma, Inc.
ATRS
| $78K | ﹤0.01% |
21,393
-21,912
| -51% | -$88.6K |
|
|
ORC
1941
Orchid Island Capital
ORC
$1.31B
| $77K | ﹤0.01% |
3,168
-1,752
| -36% | -$44.1K |
|
1942
Wave Life Sciences
WVE
$1.12B
| $77K | ﹤0.01% |
15,743
-2,947
| -16% | -$17.9K |
|
|
MRC
1943
DELISTED
MRC Global
MRC
| $76K | ﹤0.01% |
10,318
-10,570
| -51% | -$87.8K |
|
|
EIGR
1944
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $76K | ﹤0.01% |
379
-101
| -21% | -$24K |
|
1945
Inseego
INSG
$108M
| $74K | ﹤0.01% |
1,112
-1,087
| -49% | -$90.9K |
|
|
VBIV
1946
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $74K | ﹤0.01% |
795
-815
| -51% | -$77.4K |
|
|
FSP
1947
Franklin Street Properties
FSP
$44.8M
| $73K | ﹤0.01% |
15,716
-13,684
| -47% | -$66.7K |
|
|
ADVM
1948
DELISTED
Adverum Biotechnologies
ADVM
| $70K | ﹤0.01% |
3,209
-804
| -20% | -$20.5K |
|
1949
Amneal Pharmaceuticals
AMRX
$5.72B
| $68K | ﹤0.01% |
12,776
-13,094
| -51% | -$65.9K |
|
1950
Outdoor Holding Co
POWW
$239M
| $68K | ﹤0.01% |
11,035
-6,066
| -35% | -$43.7K |
|
Similar funds
ProShare Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, ProShare Advisors held 2,407 positions worth $35.6B, up 4% from $34.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
ProShare Advisors deployed $1.82B of net new capital in Q3 2021, opening 40 new positions and adding to 606 existing holdings. Its largest new stake was Sea Limited: 95,823 shares worth $30.5M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Stamps.com, Inc., an estimated $42.3M trimmed.
- ProShare Advisors's largest Q3 2021 buy was Sea Limited: 95,823 shares worth $30.5M.
- ProShare Advisors added most to Apple in Q3 2021, an estimated $172M increase.
- ProShare Advisors's biggest Q3 2021 reduction was Stamps.com, Inc., cutting an estimated $42.3M.
- ProShare Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $53.3M.
- ProShare Advisors's ten largest holdings make up 28% of its $35.6B portfolio in Q3 2021.
- ProShare Advisors opened 40 new positions and closed 406 in Q3 2021.
- ProShare Advisors's portfolio value rose 4% quarter-over-quarter to $35.6B.
Based on ProShare Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.